A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
Condition(s):Obesity and GlomerulopathyLast Updated:October 2, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Obesity and GlomerulopathyLast Updated:October 2, 2018Terminated
Condition(s):Gout; Chronic Kidney Disease (CKD)Last Updated:November 4, 2021Terminated
Condition(s):Pre-hypertension; JNC 7 Stage I HypertensionLast Updated:January 11, 2021Completed
Condition(s):Health Services ResearchLast Updated:October 19, 2022Completed
Condition(s):Primary GoutLast Updated:May 8, 2014Completed
Condition(s):Heart Failure, HyperuricemiaLast Updated:October 16, 2018Completed
Condition(s):Fructose Metabolism Disorder; Fructose Rich Diet; Metabolic Disease; Aerobic ExerciseLast Updated:May 6, 2019Completed
Condition(s):Prehypertension; Gout; Pulse Wave Velocity; Hypertension; 24 Hour Blood PressureLast Updated:December 16, 2019Completed
Condition(s):Diabetic NephropathiesLast Updated:August 3, 2021Not yet recruiting
Condition(s):HyperuricemiaLast Updated:July 14, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.